Abstract
Background A brand of fish oil capsules contains omega-3 fatty acids obtained from several fish sources. Although the manufacturer calls for caution in patients with fish hypersensitivity, insufficient data is available to make a definitive recommendation regarding its use in this population. Case presentation A patient with documented seafood allergy presented to the emergency department 4 days after the initiation of prescription brand name fish oil capsules complaining of chest tightness, shortness of breath, tingling of upper extremities, flushing, and pruritus that was minimally relieved by excessive nonprescription diphenhydramine administration. During subsequent follow-up, the patient reported that all symptoms had resolved within 5 days of discontinuing the medication and 3 days of disposing of her pillbox and all medications that had come in contact with the fish oil capsules. Conclusion Due to the patient’s allergic history, timing of onset/offset of the reaction, laboratory evidence, and the use of the Naranjo probability scale, prescription fish oil capsules were deemed the probable cause of this patient’s pruritus and flushing of the face and trunk. Practitioners and patients should always ensure they have an updated list of allergies within the patient’s medical record that includes medications as well as foods and food additives.
Notes
Lovaza® produced by Pronova Biopharma and marketed and distributed by GlaxoSmithKline in the United States of America. Pronova Biopharma also supplies same the medication under the brand name Omacor® in Europe using different network of partners for distribution and marketing, Takeda Pharmaceutical (Japan), Prospa (Italy), and Solvay (United Kingdom and Germany).
References
Husain Z, Schwartz RA. Food allergy update: more than a peanut of a problem. Int J Dermatol. 2013;52:286–94.
Sicherer SH, Munoz-Furlong A, Sampson HA. Prevalence of seafood allergy in the United States determined by a random telephone survey. J Allergy Clin Immunol. 2004;114:159–65.
Product Information: LOVAZA(R) oral capsules, omega 3 acid ethyl esters oral capsules. Research Triangle Park: GlaxoSmithKline (per FDA); 2013.
Lopata AL, Lehrer SB. New Insights into seafood allergy. Curr Opin Allergy Clin Immunol. 2009;9:270–7.
Kmet A, Unger J, Jahangir K, Kolber MR. Fish-oil capsule ingestion: a case of recurrent anaphylaxis. Can Fam Physician. 2012;58:e379–81.
Knopp RH. Evaluating niacin in its various forms. Am J Cardiol. 2000;86:51L–6L.
Naranjo CA, Busto U, Sellers EM, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981;30:239–45.
Funding
There is no funding for the writing or publishing of this manuscript.
Conflicts of interest
The authors have no conflicts of interest to disclose.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Howard-Thompson, A., Dutton, A., Hoover, R. et al. Flushing and pruritus secondary to prescription fish oil ingestion in a patient with allergy to fish. Int J Clin Pharm 36, 1126–1129 (2014). https://doi.org/10.1007/s11096-014-0017-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11096-014-0017-8